![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
"Shedding light on biosafety of platelet rich plasma." Expert Opinion on Biological Therapy, 17(8), pp. 1047–1048
Declaration of interest
BTI is a company that studies and sells PRGF technology, one type of PRP. E Anitua is the Scientific director of BTI while S Padilla and G Orive scientists at BTI. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Additional information
Funding
The authors are supported by the Laboratory of Regenerative Medicine, Biotechnology Institute BTI, Vitoria, Spain.